Glia maturation factor-gamma inhibits the proliferation of human colorectal cancer LoVo cells and affects the cytoskeletal motion of human umbilical vein endothelial cells

doi:10.3969/j.issn.2095-4344.3507

Abstract

Abstract: BACKGROUND: Glial maturation factor-gamma (GMFG) is one of the members of the ADF/cofilin superfamily protein in the process of cytoskeleton remodeling. It can regulate the cell movement by regulating actin-mediated cytoskeleton reorganization. The authors previously found that the high expression of GMFG is associated with the clinicopathological features of colorectal cancer patients, but the specific upstream and downstream mechanisms need to be explored.
OBJECTIVE: To study the effects of GMFG on cytoskeleton and LoVo cell proliferation.
METHODS: (1) Human umbilical vein endothelial cells were inoculated in a laser confocal dish. After the cells grew stably, the correlation between the expression of GMFG and the expression of cytoskeletal protein F-actin was observed by immunofluorescence staining. Colchicine inhibited mitosis. The cells were divided into control group, 0.5 mg/L colchicine group and 1.0 mg/L colchicine group. The cell cycle was observed by flow cytometry and GMFG protein expression was observed by western blot assay. (2) Human colorectal cancer LoVo cells were inoculated in a laser confocal dish. After the cells grew stably, the correlation between GMFG expression and cell cycle was observed by immunofluorescence staining. Afterwards, siRNA was used to interfere the expression of GMFG in LoVo cells. The LoVo cells were divided into blank control group, empty transfer group and siRNA-GMFG group. The cell proliferation rate was detected by Edu assay.
RESULTS AND CONCLUSION: (1) In human umbilical vein endothelial cells, the expression of GMFG was associated with the cytoskeletal motion of human umbilical vein endothelial cells, and the expression of GMFG increased when the cytoskeleton retracted. After colchicine inhibited the mitosis of human umbilical vein endothelial cells, the proportion of cells in G2/M phase increased and the expression of GMFG protein decreased with the increase of colchicine dosage. (2) In LoVo cells, the expression intensity of GMFG was associated with mitosis, and the expression of GMFG was enhanced in the middle and late stages of cell mitosis. (3) After siRNA interference with GMFG in LoVo cells, the cell proliferation rate was decreased. (4) Results verify that interference with GMFG can inhibit the proliferation rate of LoVo cells of human colorectal cancer, and there is a certain correlation between cytoskeletal motion and GMFG expression.

Key words: human umbilical vein endothelial cells, cytoskeleton, LoVo cells, cell proliferation, glia maturation factor-gamma, colchicine, colorectal cancer

CLC Number:

Wang Huili, Chen Zhijiang, Wu Bingyi. Glia maturation factor-gamma inhibits the proliferation of human colorectal cancer LoVo cells and affects the cytoskeletal motion of human umbilical vein endothelial cells[J]. Chinese Journal of Tissue Engineering Research, 2021, 25(13): 2055-2059.

Figures/Tables 5

References

[1] CHEN W, SUN K, ZHENG R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1-12.
[2] LIU S, ZHENG R, ZHANG M, et al. Incidence and mortality of colorectal cancer in China, 2011. Chin J Cancer Res. 2015;27(1):22-28.
[3] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
[4] MALVEZZI M, CARIOLI G, BERTUCCIO P, et al. European cancer mortality predictions for the year 2018 with focus on colorectal cancer. Ann Oncol. 2018;29(4):1016-1022.
[5] ZHANG Z, WANG Y, ZHANG J, et al. COL1A1 promotes metastasis in colorectal cancer by regulating the WNT/PCP pathway. Mol Med Rep. 2018;17(4):5037-5042.
[6] ZHANG X, HU F, LI G, et al. Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling. Cell Death Dis. 2018;9(2):25.
[7] ZHANG S, WANG Q, ZHOU C, et al. Colorectal cancer, radiotherapy and gut microbiota. Chin J Cancer Res. 2019;31(1):212-222.
[8] MILLER SA, POLICASTRO RA, SAVANT SS, et al. Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in PIK3CA-Mutant Colorectal Cancer. Mol Cancer Res. 2020;18(2):264-277.
[9] GANDHI M, SMITH BA, BOVELLAN M, et al. GMF is a cofilin homolog that binds Arp2/3 complex to stimulate filament debranching and inhibit actin nucleation. Curr Biol. 2010;20(9):861-867.
[10] NAKANO K, KUWAYAMA H, KAWASAKI M, et al. GMF is an evolutionarily developed Adf/cofilin-super family protein involved in the Arp2/3 complex-mediated organization of the actin cytoskeleton. Cytoskeleton (Hoboken). 2010;67(6):373-382.
[11] HARDEMAN EC, BRYCE NS, GUNNING PW. Impact of the actin cytoskeleton on cell development and function mediated via tropomyosin isoforms. Semin Cell Dev Biol. 2020;102:122-131.
[12] 李璐,黄红武. 肌动蛋白细胞骨架重构调节免疫细胞功能的研究进展[J].免疫学杂志,2019,35(8):727-731.
[13] IKEDA K, KUNDU RK, IKEDA S, et al. Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization. Circ Res. 2006; 99(4):424-433.
[14] AERBAJINAI W, GHOSH MC, LIU J, et al. Glia maturation factor-γ regulates murine macrophage iron metabolism and M2 polarization through mitochondrial ROS. Blood Adv. 2019;3(8):1211-1225.
[15] AERBAJINAI W, LIU J, KUMKHAEK C, et al. Glia maturation factor-gamma modulates M2 activation of macrophage via suppression of mitochondria function. Blood. 2017;130(Supplement 1):998.
[16] ZUO P, FU Z, TAO T, et al. The expression of glia maturation factors and the effect of glia maturation factor-γ on angiogenic sprouting in zebrafish. Exp Cell Res. 2013;319(5):707-717.
[17] AERBAJINAI W, LIU L, ZHU J, et al. Glia Maturation Factor-γ Regulates Monocyte Migration through Modulation of β1-Integrin. J Biol Chem. 2016;291(16):8549-8564.
[18] AERBAJINAI W, LIU L, KUMKHAEK C, et al. Glia maturation factor-gamma mediates human monocytes migration through regulating β1/β2-integrin recycling. Blood. 2013; 122(21):1027.
[19] SAADIYA Z, NUDRAT B, RAMLA S. Glia maturation factor gamma, is a novel diagnostic marker of leukemia, has TAL1 binding sites in its promoter. Journal of King Saud University – Science. 2020; 32:511-517.
[20] 魏星,冀静,赵永林.GMFG蛋白在宫颈癌中的表达及其与EMT的相关性[J].山西医科大学学报,2018,49(11):1306-1310.
[21] ZUO P, MA Y, HUANG Y, et al. High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer. Gynecol Oncol. 2014;132(3):745-751.
[22] 左鹏.神经胶质成熟因子γ在斑马鱼血管芽细胞迁移和卵巢癌侵袭转移中的作用及机制研究[D].杭州:浙江大学,2014.
[23] YAMAGUCHI H, CONDEELIS J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007; 1773(5):642-652.
[24] LI X, WANG J. Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis. Int J Biol Sci. 2020;16(12):2014-2028.
[25] JEONG YJ, HWANG SK, MAGAE J, et al. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway. Cell Oncol (Dordr). 2020. doi: 10.1007/s13402-020-00520-w. Online ahead of print.
[26] WANG H, CHEN Z, CHANG H, et al. Expression of glia maturation factor γ is associated with colorectal cancer metastasis and its downregulation suppresses colorectal cancer cell migration and invasion in vitro. Oncol Rep. 2017;37(2):929-936.
[27] INAGAKI M, AOYAMA M, SOBUE K, et al. Sensitive immunoassays for human and rat GMFB and GMFG, tissue distribution and age-related changes. Biochim Biophys Acta. 2004;1670(3):208-216.
[28] SHI Y, CHEN L, LIOTTA LA, et al. Glia maturation factor gamma (GMFG): a cytokine-responsive protein during hematopoietic lineage development and its functional genomics analysis. Genomics Proteomics Bioinformatics. 2006;4(3):145-155.
[29] 林文韬,王武炼,肖莉莉,等.基于GEO数据库发现骨肉瘤关键基因GMFG及其生物学功能[J].福建医药杂志, 2020,42(2):112-115.